Abstract
The Covid-19 pandemic has had a major impact on the share prices of companies in Indonesia, while the sector that received positive sentiment amid the Covid-19 outbreak is the Pharmaceutical Company Sector. The purpose of this study is to analyse the effect of earning per share, financial performance, and stock liquidity on stock returns during the Covid-19 pandemic (a case study on a pharmaceutical company listed on the Indonesia Stock Exchange). The method used in this study is quantitative. The source of data used in this study is secondary data. The sampling technique used in this research is the purposive sampling technique. This study indicates that return on equity has a significant effect on stock returns. Earnings per share and stock liquidity have no impact on stock returns.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
